World Health Organization:Latest on COVID-19

Latest on COVID-19 New COVID-19 guide for youth The new guide aims to help young people understand the science and social science of COVID-19 as well as help them take actions to keep themselves, their families and communities safe. The evolution of science and our role in preventing COVID-19 Guidance and advice will change over time. So, be open to new facts, changes, and recommendations. Remain flexible.   Search for COVID-19 info now made easier WHO’s COVID-19 webpage now features an enhanced natural language processing search bar, which understands questions posed in everyday language and more accurately delivers answers to those queries. Gender and COVID-19 Pandemics and outbreaks have differential impacts on women and men. From risk of exposure and biological susceptibility to infection to the social and economic implications, individuals’ experiences are likely to vary according to their biological and gender characteristics and their interaction with other social determinants. In case you missed it... Historic health assembly ends with global commitment to COVID-19 response Delegates of the 73rd World Health Assembly —its first-ever to be held virtually—adopted a landmark resolution to bring the world together to fight the COVID-19 pandemic. The resolution, co-sponsored by more than 130 countries, was adopted by consensus.   Find out more Other hot topics > 80 million children under one at risk of diseases such as diphtheria, measles and polio COVID 19 is disrupting life-saving immunization services around the world, putting millions of children – in rich and poor countries alike – at risk of diseases like diphtheria, measles and polio. This stark warning comes from the World Health Organization, UNICEF and Gavi, the Vaccine Alliance. WHO receives first-ever donation of insulin Fifty low- and middle-income countries are soon to receive insulin for people with diabetes, thanks to a donation by global health-care company, Novo Nordisk. The donation, to the value of US$ 1.3 million, comes at a time when many people with noncommunicable diseases such as diabetes are facing challenges with access to life-saving treatment as a result of the COVID-19 pandemic.